BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7766406)

  • 21. Isolation and characterization of nuclear proteins that bind to T cell receptor V beta decamer motif.
    Lee MR; Chung CS; Liou ML; Wu M; Li WF; Hsueh YP; Lai MZ
    J Immunol; 1992 Mar; 148(6):1906-12. PubMed ID: 1531847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequence-specific enhancer binding protein is responsible for the differential expression of ERT/ESX/ELF-3/ESE-1/jen gene in human gastric cancer cell lines: Implication for the loss of TGF-beta type II receptor expression.
    Park SH; Kim YS; Park BK; Hougaard S; Kim SJ
    Oncogene; 2001 Mar; 20(10):1235-45. PubMed ID: 11313868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential activity of the FGF-4 enhancer in F9 and P19 embryonal carcinoma cells.
    Boer B; Bernadt CT; Desler M; Wilder PJ; Kopp JL; Rizzino A
    J Cell Physiol; 2006 Jul; 208(1):97-108. PubMed ID: 16523502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Steroidogenic factor 1-dependent promoter activity of the human steroidogenic acute regulatory protein (StAR) gene.
    Sugawara T; Holt JA; Kiriakidou M; Strauss JF
    Biochemistry; 1996 Jul; 35(28):9052-9. PubMed ID: 8703908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delayed activation of HNF-3 beta upon retinoic acid-induced teratocarcinoma cell differentiation.
    Reichel RR; Budhiraja S; Jacob A
    Exp Cell Res; 1994 Oct; 214(2):634-41. PubMed ID: 7925656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of transcription factors to widely-separated cis-regulatory elements of the murine FGF-4 gene.
    Lamb K; Rosfjord E; Brigman K; Rizzino A
    Mol Reprod Dev; 1996 Aug; 44(4):460-71. PubMed ID: 8844688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A PEA3 site flanked by SP1, SP4, and GATA sites positively regulates the differentiation-dependent expression of Brachyury in embryonal carcinoma P19 cells.
    Yamaguchi H; Tanaka K; Kitagawa Y; Miki K
    Biochem Biophys Res Commun; 1999 Jan; 254(3):542-7. PubMed ID: 9920775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptional activation of the type II transforming growth factor-beta receptor gene upon differentiation of embryonal carcinoma cells.
    Kelly D; Kim SJ; Rizzino A
    J Biol Chem; 1998 Aug; 273(33):21115-24. PubMed ID: 9694866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A developmentally regulated octamer-binding activity in embryonal carcinoma cells which represses beta-interferon expression.
    Haggarty A; Camato R; Paterno G; Cohen L; Hiscott J; Skup D
    Cell Growth Differ; 1991 Oct; 2(10):503-10. PubMed ID: 1661132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of activation transcriptional factor 1 in lymphomas and in activated lymphocytes.
    Hsueh YP; Lai MZ
    J Immunol; 1995 Jun; 154(11):5675-83. PubMed ID: 7751619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptional regulation of the TGF-beta 2 gene in choriocarcinoma cells and breast carcinoma cells: differential utilization of Cis-regulatory elements.
    Kingsley-Kallesen M; Johnson L; Scholtz B; Kelly D; Rizzino A
    In Vitro Cell Dev Biol Anim; 1997 Apr; 33(4):294-301. PubMed ID: 9156346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Appearance of high affinity receptors for type beta transforming growth factor during differentiation of murine embryonal carcinoma cells.
    Rizzino A
    Cancer Res; 1987 Aug; 47(16):4386-90. PubMed ID: 2886219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IPEB transcription factor regulating the intracisternal A particle gene during F9 cell differentiation is expressed at sites of lymphoid development.
    Kamat JP; Basu A; Satyamoorthy K; Xu MQ; Showe L; Howe CC
    Mol Reprod Dev; 1995 May; 41(1):8-15. PubMed ID: 7619510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EIa-mediated transactivation of the adenovirus EIIa early promoter is restricted in undifferentiated F9 cells.
    Boeuf H; Jansen-Durr P; Kédinger C
    Oncogene; 1990 May; 5(5):691-9. PubMed ID: 2161097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential regulation of the transforming growth factor type-beta 2 gene promoter in embryonal carcinoma cells and their differentiated cells.
    Kelly D; O'Reilly MA; Rizzino A
    Dev Biol; 1992 Sep; 153(1):172-5. PubMed ID: 1516748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The embryonal carcinoma stem cell Ela-like activity involves a differentiation-regulated transcription factor.
    La Thangue NB; Thimmappaya B; Rigby PW
    Nucleic Acids Res; 1990 May; 18(10):2929-38. PubMed ID: 2140887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiation and proliferation in mouse embryonal carcinoma cells.
    Sleigh MJ
    Bioessays; 1992 Nov; 14(11):769-75. PubMed ID: 1365890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional regulation of the transforming growth factor-beta2 gene in glioblastoma cells.
    Kingsley-Kallesen M; Luster TA; Rizzino A
    In Vitro Cell Dev Biol Anim; 2001; 37(10):684-90. PubMed ID: 11776974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromosome localization and expression pattern of Lmyc and Bmyc in murine embryonal carcinoma cells.
    Ingvarsson S; Sundaresan S; Jin P; Francke U; Asker C; Sümegi J; Klein G; Sejersen T
    Oncogene; 1988 Dec; 3(6):679-85. PubMed ID: 2577870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ATF-1CREB heterodimer is involved in constitutive expression of the housekeeping Na,K-ATPase alpha 1 subunit gene.
    Kobayashi M; Kawakami K
    Nucleic Acids Res; 1995 Aug; 23(15):2848-55. PubMed ID: 7659506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.